We are live on
!
Find out more
NCM
Noesis Capital Mangement Portfolio holdings
AUM
$832M
1-Year Est. Return
49.88%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
+49.88%
3 Year Est. Return
+128.45%
5 Year Est. Return
+149.02%
10 Year Est. Return
+476.5%
AUM
$395M
AUM Growth
+$43M
(+12%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
39.44%
Holding
111
New
5
Increased
44
Reduced
24
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$10.6M |
| 2 |
Agilent Technologies
A
|
+$1.31M |
| 3 |
NextEra Energy
NEE
|
+$1.23M |
| 4 |
TSMC
TSM
|
+$663K |
| 5 |
American Express
AXP
|
+$571K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.44M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.19M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$365K |
| 4 |
Leidos
LDOS
|
+$342K |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$289K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.33% |
| 2 | Consumer Discretionary | 13.45% |
| 3 | Technology | 13.38% |
| 4 | Financials | 11.21% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $205K | 0.05% |
+2,028
| New | +$204K |
|
102
Procter & Gamble
PG
$335B
| $203K | 0.05% |
+1,363
| New | +$195K |
|
103
Verizon
VZ
$195B
| $202K | 0.05% |
+5,183
| New | +$204K |
|
104
iShares MSCI ACWI ex US ETF
ACWX
$12B
| – | – |
-5,500
| Closed | -$253K |
|
105
Automatic Data Processing
ADP
$107B
| – | – |
-1,012
| Closed | -$242K |
|
106
Elevance Health
ELV
$86.6B
| – | – |
-431
| Closed | -$221K |
|
|
107
Leidos
LDOS
$17.6B
| – | – |
-3,252
| Closed | -$342K |
|
108
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| – | – |
-2,370
| Closed | -$234K |
|
109
UnitedHealth
UNH
$364B
| – | – |
-409
| Closed | -$217K |
|
|
110
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| – | – |
-7,156
| Closed | -$365K |
|
|
MYOV
111
DELISTED
Myovant Sciences Ltd.
MYOV
| – | – |
-10,709
| Closed | -$289K |
|
Similar funds
RAM
FM
ECM
SAIG
FPCP
SCM
MPM
CB
Noesis Capital Mangement's Q1 2023 Portfolio in Review
As of Q1 2023, Noesis Capital Mangement held 111 positions worth $395M, up 12% from $352M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Noesis Capital Mangement deployed $15.9M of net new capital in Q1 2023, opening 5 new positions and adding to 44 existing holdings. Its largest new stake was BioNTech: 2,500 shares worth $311K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tesla, an estimated $1.44M trimmed.
- Noesis Capital Mangement's largest Q1 2023 buy was BioNTech: 2,500 shares worth $311K.
- Noesis Capital Mangement added most to Merck in Q1 2023, an estimated $10.6M increase.
- Noesis Capital Mangement's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.44M.
- Noesis Capital Mangement fully exited Vanguard Morningstar Mid-Cap ETF in Q1 2023, selling an estimated $365K.
- Noesis Capital Mangement's ten largest holdings make up 39% of its $395M portfolio in Q1 2023.
- Noesis Capital Mangement opened 5 new positions and closed 8 in Q1 2023.
- Noesis Capital Mangement's portfolio value rose 12% quarter-over-quarter to $395M.
Based on Noesis Capital Mangement's 13F filing for Q1 2023, filed 8 May 2023.